Kawasaki has announced the new prices of its motorcycle lineup in India, following the revised GST structure. According to the directives by the Finance Ministry, the motorcycles with engine capacity ...

Scientists from China and Canada have successfully transplanted a human kidney after the organ’s blood type was converted from type A to the universal type O using special enzymes for the first time.

TVS Motor Company has announced significant price reductions across its popular commuter motorcycles and scooters, including Jupiter and Ntorq, ahead of the festive season. This strategic move follows ...

Honda Cars India Ltd. (HCIL) has announced its revised car prices post-GST Reforms 2025, effective from today. This move builds upon the earlier commitment to pass on the full benefits of the recently ...

NHS Blood and Transplant has partnered with video game Clash Royale to drive awareness of organ donation amongst its millions of UK players. It’s the first time NHS Blood and Transplant has partnered ...

BMW Ventures share price made a steep stock market debut on Wednesday, October 1. The shares listed at a discount of 21 per cent over the IPO price. Overall, the IPO was subscribed 1.50 times, ...

Thank you for signing up! Did you know with a Digital Subscription to Shields Gazette, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...

Sept 29 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been ...

The company’s market capitalization was recorded at ₹479.83 crore following the listing of its shares. Ahead of the listing, Jinkushal Industries shares were trading at a premium of ₹20 in the grey ...

Commodity groups, ag trade associations and private companies appealed to administration officials on Thursday to designate key fertilizer and herbicide inputs as “critical minerals” to shore up ...

Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride), in the UK in 2026. The UK would be the first country in Europe to make this medicine available for adults living with ...